000 01159 a2200313 4500
005 20250516211800.0
264 0 _c20141215
008 201412s 0 0 eng d
022 _a1933-2874
024 7 _a10.1016/j.jacl.2014.03.003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJacobson, Terry A
245 0 0 _aNLA Task Force on Statin Safety--2014 update.
_h[electronic resource]
260 _bJournal of clinical lipidology
_c
300 _aS1-4 p.
_bdigital
500 _aPublication Type: Introductory Journal Article
650 0 4 _aAge Factors
650 0 4 _aCardiovascular Diseases
_xdrug therapy
650 0 4 _aCholesterol, LDL
_xblood
650 0 4 _aGlycated Hemoglobin
_xanalysis
650 0 4 _aHumans
650 0 4 _aHydroxymethylglutaryl-CoA Reductase Inhibitors
_xadverse effects
650 0 4 _aKidney Diseases
_xetiology
650 0 4 _aLiver Diseases
_xetiology
650 0 4 _aMuscular Diseases
_xetiology
650 0 4 _aNeurodegenerative Diseases
_xetiology
773 0 _tJournal of clinical lipidology
_gvol. 8
_gno. 3 Suppl
_gp. S1-4
856 4 0 _uhttps://doi.org/10.1016/j.jacl.2014.03.003
_zAvailable from publisher's website
999 _c23793106
_d23793106